Brief: Spectrum Pharmaceuticals Reports Fourth Quarter 2022 And Full Year 2022 Financial Results And Corporate Update
22/03/2023 12:11
March 22 (Reuters) - Spectrum Pharmaceuticals Inc
SPPI.O :
* SPECTRUM PHARMACEUTICALS REPORTS FOURTH QUARTER 2022 AND
FULL
YEAR 2022 FINANCIAL RESULTS AND CORPORATE UPDATE
* SPECTRUM PHARMACEUTICALS INC - NET SALES FOR QUARTER $10.1
MILLION
* SPECTRUM PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.06
* SPECTRUM PHARMACEUTICALS INC - HAD TOTAL CASH, CASH
EQUIVALENTS,
AND MARKETABLE SECURITIES BALANCE OF APPROXIMATELY $75.1 MILLION
AT DEC 31, 2022
Source text for Eikon: ID:nBwcbyyqMa
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary